La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Argosy Research Salute del bilancio

Salute finanziaria criteri di controllo 6/6

Argosy Research ha un patrimonio netto totale di NT$4.2B e un debito totale di NT$0.0, che porta il suo rapporto debito/patrimonio netto a 0%. Le sue attività totali e le sue passività totali sono rispettivamente NT$5.7B e NT$1.5B. L'EBIT di Argosy Research è NT$948.5M rendendo il suo rapporto di copertura degli interessi -16. Ha liquidità e investimenti a breve termine pari a NT$1.8B.

Informazioni chiave

Rapporto debito/patrimonio netto

NT$0

Debito

Indice di copertura degli interessi	-16x
Contanti	NT$1.80b
Patrimonio netto	NT$4.16b
Totale passività	NT$1.53b
Totale attività	NT$5.69b

Aggiornamenti recenti sulla salute finanziaria

Is Argosy Research (GTSM:3217) Using Too Much Debt?

Feb 28

Recent updates

Are Strong Financial Prospects The Force That Is Driving The Momentum In Argosy Research Inc.'s GTSM:3217) Stock?

Dec 24

The 24% Return On Capital At Argosy Research (GTSM:3217) Got Our Attention

Dec 06

Argosy Research (GTSM:3217) Has Rewarded Shareholders With An Exceptional 999% Total Return On Their Investment

Nov 18

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( NT$3.4B ) di 3217 superano le sue passività a breve termine ( NT$1.4B ).

Passività a lungo termine: Le attività a breve termine di 3217 ( NT$3.4B ) superano le sue passività a lungo termine ( NT$106.7M ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: 3217 è esente da debiti.

Riduzione del debito: 3217 non ha debiti rispetto a 5 anni fa, quando il suo rapporto debito/patrimonio netto era 6.3%.

Copertura del debito: 3217 non ha debiti, pertanto non deve essere coperto dal flusso di cassa operativo.

Copertura degli interessi: 3217 non ha debiti, pertanto la copertura dei pagamenti degli interessi non è un problema.

Argosy Research Salute del bilancio

Salute finanziaria criteri di controllo 6/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

Is Argosy Research (GTSM:3217) Using Too Much Debt?

Recent updates

Second quarter 2024 earnings: EPS exceeds analyst expectations

Now 21% undervalued after recent price drop

Argosy Research Inc. to Report Q2, 2024 Results on Jul 24, 2024

Dividend of NT$6.40 announced

Argosy Research Inc. Approves Cash Dividends, Payable on July 31, 2024

First quarter 2024 earnings: EPS in line with expectations, revenues disappoint

Argosy Research Inc. to Report Q1, 2024 Results on Apr 25, 2024

Price target increased by 14% to NT$200

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Now 23% undervalued

Argosy Research Inc., Annual General Meeting, Jun 12, 2024

Argosy Research Inc. Announces Resignation of Lu,Cheng-Xi as Chief Internal Auditor, Effective from February 29, 2024

Now 20% undervalued

Investor sentiment improves as stock rises 28%

Second quarter 2023 earnings: EPS in line with analyst expectations despite revenue beat

Upcoming dividend of NT$5.35 per share at 4.0% yield

New minor risk - Share price stability

Investor sentiment improves as stock rises 19%

Full year 2022 earnings: EPS exceeds analyst expectations

Now 20% undervalued

Now 23% undervalued

Consensus EPS estimates fall by 11%

Price target decreased to NT$81.00

Investor sentiment improved over the past week

Price target decreased to NT$81.00

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorated over the past week

Upcoming dividend of NT$5.60 per share

Consensus revenue estimates fall by 15%

Price target decreased to NT$116

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Price target increased to NT$160

Investor sentiment improved over the past week

Price target increased to NT$141

Investor sentiment improved over the past week

Price target increased to NT$130

Third quarter 2021 earnings released: EPS NT$2.35 (vs NT$1.95 in 3Q 2020)

Price target decreased to NT$120

Second quarter 2021 earnings released: EPS NT$1.47 (vs NT$1.96 in 2Q 2020)

Upcoming dividend of NT$5.60 per share

Price target decreased to NT$144

Investor sentiment deteriorated over the past week

A Look At The Intrinsic Value Of Argosy Research Inc. (GTSM:3217)

Full year 2020 earnings released: EPS NT$7.20 (vs NT$5.34 in FY 2019)

Will Argosy Research (GTSM:3217) Become A Multi-Bagger?

Is Argosy Research (GTSM:3217) Using Too Much Debt?

New 90-day high: NT$134

How Does Argosy Research Inc. (GTSM:3217) Fare As A Dividend Stock?

New 90-day high: NT$121

Calculating The Fair Value Of Argosy Research Inc. (GTSM:3217)

Is There More To The Story Than Argosy Research's (GTSM:3217) Earnings Growth?

Are Strong Financial Prospects The Force That Is Driving The Momentum In Argosy Research Inc.'s GTSM:3217) Stock?

The 24% Return On Capital At Argosy Research (GTSM:3217) Got Our Attention

Argosy Research (GTSM:3217) Has Rewarded Shareholders With An Exceptional 999% Total Return On Their Investment

Third quarter 2020 earnings released: EPS NT$1.95

New 90-day low: NT$105

First half earnings released

Analisi della posizione finanziaria

Storia e analisi del rapporto debito/patrimonio netto

Bilancio

Scoprire le aziende sane